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INTRODUCTION:  Benign  thyroglossal  duct  tract  remnants  typically  thyroglossal  duct cysts,  (TDCs)  are  one
of  the  commonest  congenital  childhood  midline  neck  masses.  Clinical  presentation  of persistent  TDCs  in
adults  is  uncommon  and the occurrence  of  incidental  primary  thyroid  papillary  carcinoma  (TPC)  in  these
cysts  is  rare.
PRESENTATION  OF  CASE:  We  report the  case  of  a  32-year-old  female  with  an  asymptomatic  midline  neck
mass  compatible  with  a  TDC  that  was  excised  by Sistrunk’s  procedure.  Histopathological  examination
revealed  an  incidental  primary  intraluminal  TPC  arising  from  the  wall  of  the  TDC.hyroid papillary carcinoma
hyroglossal  duct cyst
hyroglossal  duct remnants
anagement  guidelines
isk  stratiﬁcation
DISCUSSION: Management  dilemmas  regarding  the  roles  for  total  thyroidectomy,  regional  lymph  node
dissection,  radioactive  iodine,  and suppressive  thyroxine  therapy  are  reviewed  in  the  context  of  relevant
evidence  based  literature.
CONCLUSION: The  occurrence  of incidental  TPC  in  a TDC  is  rare.  Though  Sistrunk’s  procedure  is adequate
treatment  for  TDC,  based  on  low,  moderate,  and  high  risk  stratiﬁcation,  recommendations  for  further
management  of incidental  TPC  in  TDC  is  discussed.
gical © 2012 Sur
. Introduction
TDCs are one of the most common (75%) asymptomatic mid-
ine congenital neck masses in childhood.1–3 Persistent TDCs occur
arely (7%) in adults.1,3,4 Amongst all cancers, thyroid carcinoma is
elatively uncommon (2%).5 Reported cases of thyroid carcinomas
ccurring in TDC are extremely uncommon (1–2%).1–3,6,7
Though described in 1911 by Brentano, the ﬁrst reported case
n the English literature of a primary TPC in a TDC is by Owen
nd Ingelby in 1927.1,3,7 Controversies exist even today regarding:
a) exact origin and (b) optimal management for incidental TPC in
DC.1–3,7–9
Majority of TPCs in TDCs are discovered as an incidental ﬁnd-
ng on pathological examination of the excised cyst specimen
reated by Sistrunk’s procedure based on the embryological devel-
pment of the thyroid gland.9–13 Simple local excision of TDC is no
onger advised due to recurrences related to incomplete removal
f the thyroglossal tract.1,9 The rare discovery of an incidental
PC in a TDC raises questions regarding best practice guidelines
or further management which still remains controversial and
ebatable.1,9,13,14
We  report the case of an incidental primary intraluminal well-
ifferentiated TPC arising in a TDC and discuss the potential roles for
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total thyroidectomy, regional lymph-node dissection, radioactive
iodine, and suppressive thyroxine therapy as adjuvant therapy in
the context of relevant evidence-based literature.
2. Presentation of case
2.1.  Case report
A  32-year-old female who  presented with a painless 3 cm
swelling in the anterior aspect of the neck, clinically compatible
with a TDC was  treated by a standard Sistrunk’s procedure.
Histopathological examination showed the presence of 0.8 cm
papillary neoplasm arising from the cyst wall which contained
entrapped thyroid follicles in keeping with a TDC (Fig. 1a).
Microscopic examination of the papillary neoplasm showed the
presence of complex ﬁbrovascular cores lined by epithelium with
characteristic nuclear features of well-differentiated low grade
TPC (Fig. 1b). No additional histological subtypes were identiﬁed.
Immunohistochemical staining with antibodies to low molecular
weight keratin, thyroid transcription factor-1 (TTF-1), and thy-
roglobulin were strongly positive both in the papillary neoplasm
and the residual trapped non-neoplastic thyroid follicles (Fig. 1c).
The TPC arising in the TDC was completely excised with no evi-
Open access under CC BY-NC-ND license.dence of invasion of the underlying cyst wall. No further surgical
treatment was undertaken as this was considered an incidental
well-differentiated classical thyroid papillary microcarcinoma.
1-year follow up was unremarkable.
 BY-NC-ND license.
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Fig. 1. (a–c) Photomicrographs of TPC arising in the wall of the TDC. (a) Haematoxylin and eosin stained slides at low magniﬁcation (lens objective 2×) show the presence of
a  papillary neoplasm arising from the cyst wall which contained entrapped thyroid follicles (black arrow→) in keeping with a thyroglossal duct cyst. (b) Haematoxylin and
eosin  stained slides at high magniﬁcation (lens objective 10×) conﬁrms the presence of papillae with complex ﬁbrovascular cores lined by the typical nuclei (ground glass
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.2. Review of Management Dilemmas of TPC in TDC
A  Literature search using PubMed, Medline, Scopus, Embase,
nd Google/Google Scholar limited to the English language using
he search terms ‘thyroid papillary carcinoma’ AND ‘thyroglossal
uct cyst’ AND thyroglossal duct remnants’ AND ‘management’ was
onducted.
. Discussion
The thyroid gland is one of the earliest endocrine glands to
evelop in the human embryo.10 It descends from the foramen
ecum at the base of the tongue to the front of the neck in close
elation to the hyoid bone via the thyroglossal duct. Thyroglossal
uct remnants, most commonly a cyst, develops due to incom-
lete atrophy of the duct which usually occurs by the 7th foetal
eek of gestation.13 TDC is the most common non-odontogenic
yst that presents as a neck mass at any point along the tract rep-
esenting more than 75% of childhood midline neck masses. It is
are in the adult population (7%).1,2,4,7,15 TDC clinically presents
s a soft/ﬁrm/hard/ﬂuctuant mass, that is generally movable in
he midline of the neck. TDCs occur along the thyroglossal tract:
hyrohyoidal (61%), suprahyoidal (24%), suprasternal (13%), and
ntra-lingual region (2%).1
The development of malignancy in TDC is uncommon and
pproximately 200 cases are reported in the English literature since
ts ﬁrst description in 1911.1,3,6,13
In up to two-thirds of TDCs, thyroid follicles that persist in the
yst wall can rarely undergo neoplastic transformation.3 TPC is the
ost common histological type of (80%) malignancy that occurs in
DCs. Infrequently squamous, follicular, mixed papillary/follicular,
ürthle cell and anaplastic carcinoma have been reported.1,2
The exact origin of TPC in a TDC is still debated as to whether
t represents a ‘metastatic lesion’ from an occult primary TPC in
he thyroid gland versus its ‘de novo origin’.1,2,7,8,12,14 The pres-
nce of entrapped thyroid follicles in the cyst wall, as seen in our
ase (Fig. 1a), and the persistent absence of medullary carcinoma
ccurring in a TDC in keeping with its embryology, strongly favours
he ‘de novo theory’.1,2,16
The diagnosis of a carcinoma in a TDC is usually incidental with
o additional clues to suspect this preoperatively at the initial clin-
cal presentation.1 The diagnosis of primary TPC in a TDC is one
f exclusion using the Widstrom criteria which include: (1) car-
inoma should be in the wall of the thyroglossal duct remnant,
2) carcinoma must be differentiated from a cystic lymph node
etastasis by histological demonstration of a squamous or colum-
ar epithelium lining and normal thyroid follicles in the wall of
he thyroglossal duct remnant, and (3) there should be no malig-
ancy in the thyroid gland or any other possible primary site.1,7a. (c) Immunohistochemical stained slides at low magniﬁcation (lens objective 2×)
nd thyroglobulin in the residual trapped thyroid follicles in the cyst wall and the
This latter criterion is highly debated as 11–45% of all thyroglos-
sal duct remnant carcinoma cases have a synchronous thyroid
carcinoma.1,3
Pre-operative thyroid scan, ultrasound guided ﬁne needle aspi-
ration cytology (US-FNAC) and CT/MRI imaging of the neck are
gaining more popularity to enhance the accuracy of preoperative
diagnosis.2,17 Although, preoperative thyroid scans conﬁrm the
presence of ectopic thyroid tissue in 33% of TDCs, such scans have
not been beneﬁcial in the preoperative diagnoses of carcinoma in
TDCs.9 US-FNAC though simple, rapid, inexpensive with minimal
risk complications is more reliable in diagnosing solid tumours
rather than cystic lesions. Additionally, FNAC is not cost-effective
due to the rarity of this malignancy and remains an inappropri-
ate tool for routine use in children.1,2,18 CT/MRI imaging of the
neck are rarely indicated preoperatively unless there is a high clini-
cal/FNAC suspicion of malignancy.1,2,7,17 Imaging features such as a
solid nodule with calciﬁcation/irregular margin/thick wall are sug-
gestive of malignancy.2,7 Ogawa et al. have suggested a possible
utilization of three-dimensional computed tomography in provid-
ing accurate pre-operative diagnosis of TPC in a TDC.19
The dilemma involved with the further management of the
discovery of incidental TPC arising in a TDC, is largely related
to whether additional management protocols such as total thy-
roidectomy, regional lymph node dissection, radioactive iodine,
and suppressive thyroxine therapy are warranted; as involvement
of the thyroid gland has been reported in up to 11–45% of cases
wherein a completion thyroidectomy was performed.1,12 Such
ﬁndings also raise the possibility of the presence of multifocal dis-
ease arising from synchronous TPC in the TDC and the native thyroid
gland.1,3,20
In Patel et al’s analysis of 57 cases of well-differentiated car-
cinomas in TDC, the only signiﬁcant predictor for overall survival
was the completeness of excision of TDC.8 Patients treated with
simple excision (10-yr survival 75%) had a worse prognosis than
those with Sistrunk’s procedure (100%).1 It is hard to justify total
thyroidectomy as the overall cure rate of a carcinoma arising in a
TDC treated by Sistrunk’s procedure is over 95%.9
Recently, prognostic risk group assessments are used to
identify patients who would beneﬁt from additional total
thyroidectomy.1,2,7,8 Plaza et al. identiﬁed high risk factors: (a)
age >45 years, (b) past radiation exposure, (c) presence of tumour
in the thyroid gland on radiological evaluation, (d) presence of
clinical/radiological nodes, (e) tumour >1.5 cm in diameter, (f)
cyst-wall invasion, and (g) positive margins on histopathological
examination as indicators for additional total thyroidectomy with
radioiodine and suppressive hormone therapy.1 Additional factors
that guide therapy/risk assessment include gender, and tumour
characteristics such as histological grade/type, tumour focality, and
lymphovascular invasion.21
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Regional lymph node metastases have been reported in up to
–15%. When nodal metastases are detected preoperatively, total
hyroidectomy and regional neck dissection are recommended in
ddition to Sistrunk’s procedure.1 Prophylactic lateral neck dissec-
ion in the absence of detectable nodal metastases is not routinely
ecommended.1,2,6,8 In selected cases, therapeutic nodal dissection
s limited to central compartment neck dissection in keeping with
hese midline tumours.6
Suppressive hormone therapy and radioactive iodine are rec-
mmended in all post-total thyroidectomy patients. In patients
reated by Sistrunk’s procedure alone suppression therapy is rec-
mmended to suppress the thyroid tissue and to keep the thyroid
timulating hormone (TSH) levels between 0.1 and 0.5 mIU/L.
nnual TSH levels and ultrasound scans of the neck are rec-
mmended in the follow-up management protocols for these
atients.1 Proposed recommendations for the management of inci-
ental TPC in TDC based on stratiﬁcation of low, moderate, and high
isk groups are presented in Fig. 2.
Papillary cancer is known to have a prolonged clinical course
herefore long term follow up (>20 years) is recommended.3 The
verall prognosis for TPC arising in a TDC is excellent with (a)
eported 10-year survival rates of 95.6% and (b) distant metastatic
ate of <2%.8,16
. Conclusions
Primary TPC in adult TDCs is uncommon with the majority
eing diagnosed post-operatively as an incidental ﬁnding on deﬁni-
ive histopathological examination. The long-term management of
hese patients is based on their stratiﬁcation of low, moderate, and
igh risk groups. Though the overall prognosis for Incidental TPC
rising in TDC is excellent, long term clinical follow up is recom-
ended due to the prolonged natural clinical course of TPC.edical  disclaimer
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